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ABSTRACT
SINE-VNTR-Alu (SVA) elements are non-
autonomous, hominid-specific non-LTR retrotrans-
posons and distinguished by their organization as
composite mobile elements. They represent the
evolutionarily youngest, currently active family
of human non-LTR retrotransposons, and sporad-
ically generate disease-causing insertions. Since
preexisting, genomic SVA sequences are char-
acterized by structural hallmarks of Long
Interspersed Elements 1 (LINE-1, L1)-mediated
retrotransposition, it has been hypothesized for
several years that SVA elements are mobilized by
the L1 protein machinery in trans. To test this
hypothesis, we developed an SVA retrotransposition
reporter assay in cell culture using three different
human-specific SVA reporter elements. We demon-
strate that SVA elements are mobilized in HeLa cells
only in the presence of both L1-encoded proteins,
ORF1p and ORF2p. SVA trans-mobilization rates
exceeded pseudogene formation frequencies by
12- to 300-fold in HeLa-HA cells, indicating that
SVA elements represent a preferred substrate for
L1 proteins. Acquisition of an AluSp element
increased the trans-mobilization frequency of the
SVA reporter element by 25-fold. Deletion of (CC
CTCT)n repeats and Alu-like region of a canonical
SVA reporter element caused significant attenuation
of the SVA trans-mobilization rate. SVA de novo
insertions were predominantly full-length, occurred
preferentially in G+C-rich regions, and displayed all
features of L1-mediated retrotransposition which
are also observed in preexisting genomic SVA
insertions.
INTRODUCTION
Three different families of non-LTR retrotransposons are
actively mobilized in the human genome. These are Long
Interspersed Elements 1 (LINE-1, L1), Alu elements
(Short Interspersed Elements, SINE) and SVA (SINE-
VNTR-Alu) elements. Their success is documented by
the fact that non-LTR retrotransposons encompass
34% of the human genome, making them the most
populous group of transposable elements in the human
genome (1). L1 elements are the only currently known
retrotransposons in the human genome that are coding
for the protein machinery required for their own mobil-
ization. Despite the cis-preference (2) of L1 proteins for
their own encoding RNA, RNA polymerase III tran-
scripts [Alu, 7SL, U6 and hY sequences (3–6)] mutated
full-length L1 RNAs (2), and cellular mRNAs [resulting
in processed pseudogene formation (7–9)] were experimen-
tally demonstrated to be trans-mobilized by hijacking the
L1-encoded protein machinery
Since genomic preexisting insertions of the hominid-
speciﬁc non-autonomous non-LTR retrotransposon SVA
exhibit the classical hallmarks of L1-mediated
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retrotransposition (10–12,24), SVA was also assumed to
use the L1 protein machinery for its own mobilization
(13). These hallmarks are: (i) insertion at a 50-TTTT/
AA-30 consensus sequence of the L1 endonuclease recog-
nition motif, (ii) 4- to 20-bp target site duplications
(TSDs) ﬂanking each SVA insertion, (iii) poly(A) tails of
varying lengths at their 30-ends, (iv) presence of
50-truncated SVA insertions, (v) internal rearrangements
and inversions (13–15) and (vi) 30-transductions (16,17).
SVA is a composite retrotransposon and present in
about 2700 copies (12) in the human genome reference
sequence. Approximately 30% of them have been
integrated after the divergence of humans and chimpan-
zees (18). The origin of SVA elements can be traced back
to the beginnings of hominid primate evolution, 18–25
Mya. Starting at the 50-end, a full-length SVA element is
composed of a (CCCTCT)n hexamer repeat region; an
Alu-like region consisting of two antisense Alu fragments
and an intervening unique sequence; a variable number of
tandem repeats (VNTR) region, which is made up of
copies of a 36- to 42-bp sequence or of a 49- to 51-bp
sequence (13), presumably derived from the SVA2
element found in Rhesus macaques and humans (19–22);
and a short interspersed element of retroviral origin
(SINE-R) region (22). A poly(A) tail is positioned down-
stream of the predicted conserved polyadenylation
signal AATAAA (13). Seven different SVA variants exist
in hominid genomes, including 50- or 30-transductions, or
both 50- and 30- transductions (21,23). The in vivo
retrotransposition rate of the SVA retrotransposon
family was recently estimated to be one in 916 births (25).
Several observations indicate that SVA elements consti-
tute a highly active family of hominid-speciﬁc non-LTR
retrotransposons whose mobilization rate exceeds pro-
cessed pseudogene formation frequencies: First, seven
SVA insertions were found to be associated with disease
[for review see (24)] suggesting that SVA mobilization
in vivo is currently more efﬁcient than the formation of
high-copy pseudogenes, which have not been found to be
associated with any human disease so far. Second, the
identiﬁed disease-causing SVA insertions are derived
from different source elements of the SVA subfamilies
D, E, F and F1, and SVAs from these subfamilies are
polymorphic in humans (11,12,21). It was estimated that
40% of the SVA elements in the human genome are
polymorphic (11). Also, 14 SVA insertions were recently
identiﬁed in the HuRef sequence that are not present in
the haploid human genome reference sequence from
the HGP (25). Lastly, each mRNA pseudogene originates
from primarily one source locus, while retrotransposed
SVAs are derived from multiple SVA source loci (16,21).
We set out to test the hypothesis that the L1 protein
machinery is mobilizing SVA elements in trans by estab-
lishing an SVA retrotransposition reporter assay in cell
culture. We compared the rate of processed pseudogene
formation with the trans-mobilization frequencies of
two human-speciﬁc SVA elements that were identiﬁed
as potential source elements. We found that SVA RNAs
transcribed from the retrotransposition reporter plasmids
are trans-mobilized 12- to 300-fold more efﬁciently than
RNA-Pol II transcripts expressed from a pseudogene
formation reporter plasmid in HeLa-HA cells.
Furthermore, we demonstrate that the hexameric (CCCT
CT)n repeat/Alu-like region at the 5
0-end of canonical SVA
elements and the 30-transduced AluSp sequence of an SVA
source element have different effects on SVA retrotran-
sposition frequencies in cell culture. Marked SVA de
novo insertions were predominantly full-length and ex-
hibited all structural features of L1-mediated retrotran-
sposition that are observed in pre-existing genomic SVA
insertions.
MATERIALS AND METHODS
Isolation of genomic SVAE and SVAF1 elements
Based on two recent publications (26,21), we selected two
potentially functional human-speciﬁc SVA elements as
retrotransposition reporter elements. In order to isolate
the member of the SVA subfamily E (SVAE) that served
as source element of a reported retrotransposition
event into the LDLRAP1 gene (26), we performed a
BLAT search of the human genome reference sequence
(hg17; May 2004), using the partially published sequence
of this disease-causing SVA insertion as a query to identify
its potential source element. We observed 100% identity
between query sequence and genomic SVAE element
H19_27 (21). Since the human genome is polymorphic
for this SVA insertion, we ampliﬁed this SVA element
from a BAC clone (RP11-420K14 [AC092364] obtained
from the Roswell Park Cancer Institute (Buffalo, NY,
USA) via the RZPD-Deutsches Ressourcenzentrum fu¨r
Genomforschung) by PCR using primers chrom19-
gen-FW and chrom19-gen-REV (Supplementary Table
S1) which are speciﬁc for the genomic sequences
ﬂanking SVA H19_27. PCRs were performed using the
Expand Long Template PCR System (Roche) and
controlled by sequence analyses. The resulting 2-kb
PCR product was subcloned into the pGEM-T Easy
vector (Promega). Subsequent sequence analysis of the
cloned PCR product revealed that the ampliﬁed SVA
element harbors only 21 VNTR subunits instead of 33
VNTR subunits speciﬁed in the human genome reference
sequence. This ﬁnding was conﬁrmed by sequence analysis
of three independent PCR ampliﬁcations of SVA H19_27
located on the BAC clone performed with three different
primer pairs. We conclude that the nucleotide sequence of
the VNTR region of SVA H19_27 on the BAC clone
differs from the corresponding sequence of the human
genome reference sequence. To isolate the SVA element
H10_1 (21) which is a source element of the SVA subfam-
ily F1 (SVAF1) together with its 3
0-ﬂanking AluSp
sequence, we ampliﬁed the corresponding genomic
fragment from the BAC clone RPCIB753F0114Q
[AL392107] (ImaGenes) by PCR with primers H10_1
For1 and H10_1 Rev1 (Supplementary Table S1).
The resulting 4291-bp PCR product was subcloned into
the pTZ57R vector (Fermentas) leading to pTZ H10_1.
The subcloned PCR product was veriﬁed by sequence
analyses.
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Retrotransposition reporter constructs and mutant L1
protein donor plasmids
pCEPneo. The mneoI indicator cassette of pJM101/L1.3
(61) was PCR ampliﬁed using the primers Neo-Nhe-FW
and Neo-BamHI-REV (Supplementary Table S1), and
subcloned into pGEM-T Easy. Next, the mneoI cassette
was removed by NheI/BamHI digestion and inserted into
pCEP4 (Invitrogen) downstream of the CMV promoter
(CMVP) and in opposite transcriptional orientation
relative to the CMV promoter (Figure 1A).
pAD3/SVAE. The subcloned SVA H19_27 element was
reampliﬁed by PCR using primers CT-up-Kpn and
DOWN--pA (Supplementary Table S1). The resulting
fragment is devoid of the SINE-R-encoded poly-
adenylation signal and was inserted between CMVP
and the mneoI indicator cassette of pCEPneo via
KpnI/NheI. CMVP -driven SVA transcription in pAD3/
SVAE reads into the mneo indicator cassette to be
terminated by the pCEP4-encoded SV40 polyadenylation
signal.
pAD4/SVAE.. pAD4/SVAE differs from pAD3/SVAE in
the absence of the initial 499 nt of the 50-end of SVA
H19_27 covering the (CCCTCT)n hexameric repeats
and the Alu-like region. To generate pAD4/SVAE, the
reampliﬁed SVA H19_27 fragment was digested with
AlwNI and NheI. The resulting 1380-bp fragment was
cloned between the CMVP and the mneoI indicator
cassette of pCEPneo via KpnI/blunt/AlwNI and NheI
(Figure 1A).
pSC3/SVAF1. To remove the transcriptional termination
signal at the SINE-R 30-end of SVAF1 source element
H10_1 for subsequent cloning steps, the H10_1 sequence
was reampliﬁed from pTZ H10_1 using the primer pair
H10_1 For2 and H10_1 Rev2 including KpnI and NheI
restriction sites, respectively (Supplementary Table S1).
The resulting 3527-bp PCR product was inserted into
pGEM-T Easy, excised from the resulting plasmid
pGEM H10_1 by KpnI/NheI digestion, and inserted
between the CMVP and the mneoI indicator cassette of
pCEPneo via KpnI/NheI, yielding pSC3/SVAF1.
pSC4/SVAF1. The synthetic oligonucleotide sequence
A14TTTA26 (Generi Biotech) was fused as NheI/SpeI
fragment into the NheI site of the SINE-R 30-end of
pGEM H10_1, substituting for the AATAAA-containing
polyA tail at the 30-end of the genomic SVA H10_1
element. The resulting plasmid pGEM-H10_1/pA.
AluSp was ampliﬁed from pTZ H10_1 using oligonucleo-
tides H10_1 AluFor2 and H10_1 AluRev2 including SpeI
and SalI restriction sites, respectively (Supplementary
Table S1), and subcloned into pGEM-T Easy. The
389-bp SpeI/SalI AluSp fragment was fused with the
30-end of the A14TTTA26 stretch of pGEM-H10_1/pA
via SpeI/SalI resulting in pGEM-H10_1+Alu. The
3940-bp H10_1/A14TTTA26/AluSp-fragment was inserted
between CMVP and mneoI cassette of pCEPneo via KpnI
and NheI/SalI blunt, yielding pSC4/SVAF1.
pJM101/L1RPDneoDORF1 (L1RPDORF1). pJM101/
L1RPneoORF1 was generated by introducing a
330-bp in-frame deletion in L1 ORF1 of pJM101/
L1RPneo (2). The deletion was accomplished by XhoI/
SapI-restriction of pJM101/L1RPneo and subsequent
religation after blunt-ending.
Cell culture, SVA retrotransposition reporter assays and
statistical analyses
Cell lines HeLa-JVM and HeLa-HA (28) were cultured in
DMEM High Glucose (Biochrom AG, Berlin, Germany)
supplemented with 10% FCS (Biowest, Nuaille´, France),
100 mg/ml streptomycin and 100U/ml penicillin. To
perform retrotransposition reporter assays with initial
hygromycin selection for the presence of retrotran-
sposition reporter plasmid and L1 protein donor
plasmid, 1.8 106 cells were plated on 10-cm dishes or
T75-ﬂasks. Plated cells were cotransfected with 3 mg of
an SVA retrotransposition reporter plasmid or pCEPneo
and 3 mg of an L1 protein donor construct (pJM101/
L1RPneo, pJM101/L1RPneoORF1) or pCEP4
(negative control) using FUGENE 6 (Roche) according
to the manufacturer’s instructions. Each cotransfection
was performed twice or thrice in quadruplicate: In each
case, three cotransfections were used to quantify
retrotransposition rates of the SVA reporter elements
and pseudogene formation rates of the pCEPneo con-
struct. The fourth cotransfection was used to isolate cell
lysates and total RNA in order to analyze expression of
retrotransposition reporter cassettes and L1-speciﬁc gene
products expressed from the L1 donor plasmids. Starting
24 h post-transfection, cells were subjected to hygromycin
(200 mg/ml, Invitrogen) selection for 14 days. After
trypsinization and reseeding, cells were selected for
L1-mediated retrotransposition events in medium contain-
ing 400mg/ml G418 (Invitrogen). After 11–12 days of
selection, G418R colonies were either ﬁxed an stained
with Giemsa (Merck) to quantify retrotransposition
events as described previously (27), or individual G418R
colonies were isolated and expanded to characterize SVA
de novo retrotransposition events.
To perform retrotransposition reporter assays after
transient cotransfection of the respective reporter
plasmid and L1 donor plasmid (without hygromycin
selection), 2.8 106 cells were plated on 15-cm dishes,
and transiently cotransfected with 8 mg of the reporter
plasmids pAD3/SVAE, pAD4/SVAE or pCEPneo and
8 mg of either pJM101/L1RPneo or pCEP4 using
FUGENE 6. Each cotransfection was performed four
times in parallel. HeLa cells resulting from one transient
cotransfection experiment each were used to analyze the
expression of ORF1p encoded by pJM101/L1RPneo.
Cells were trypsinized 2 days after transfection,
re-seeded, and cultivated in G418 containing medium for
14 days. The cis-retrotransposition rate which was
observed after cotransfection of pJM101/L1RP and
pCEP4 served as positive control and was set as 100%.
To obtain countable results for retrotransposition in
cis, only 1 104 cells were plated for G418 selection.
Transfection efﬁciency was determined by cotransfecting
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Figure 1. Rationale of the SVA trans-mobilization assay. (A) Schematic representation of SVA retrotransposition reporter plasmids, and
pseudogene-formation control construct pCEPneo. SVA reporter elements in pAD3/SVAE, pAD4/SVAE, pSC3/SVAF1 and pSC4/SVAF1 and the
processed pseudogene formation cassette in pCEPneo were each tagged with the indicator gene mneoI, and set under transcriptional control of the
human CMV promoter (CMVP). Splice donor (SD) and splice acceptor (SA) sites of the oppositely oriented g-globin intron are indicated. mneoI is
ﬂanked by a heterologous promoter (P0) and a polyadenylation signal (A0). Transcripts originating from CMVP driving SVA mneoI or CEP mneoI
transcription can splice the intron, but contain an antisense copy of the neo gene. G418 resistant (G418R) colonies arise only if this transcript is
reverse transcribed, integrated into chromosomal DNA, and expressed from its own promoter P0. Each SVA reporter element was inserted between
CMVP and the mneoI cassette. pAD4/SVAE, differs from pAD3/SVAE in the deletion of the initial 498 nt of the SVA 5
0-end covering (CCCTCT)n-
and Alu-like region. pSC4/SVAF1 varies from pSC3/SVAF1 in the insertion of the 389-bp AluSp element fused to the A14TTTA26 stretch between
Nucleic Acids Research, 2012, Vol. 40, No. 4 1669
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4 mg of pEGFP-N1 (Clontech), 4 mg of pAD3/SVAE,
pAD4/SVAE or pCEPneo and 8 mg of the L1 donor
plasmid into 2.8 106 HeLa-JVM cells using FUGENE
6. EGFP expressing cells were counted 24 h post-
transfection by ﬂow cytometry. The percentage of green
ﬂuorescent cells was used to determine the transfection
efﬁciency of each sample (2,29). Statistical evaluation
was performed by means of an Analysis of Variance
(ANOVA). To control the overall type I error a=0.05,
P-values were adjusted according to Dunnett for multiple
comparisons. The statistical analysis was performed with
SAS/STAT software, version 9.2 SAS system for
Windows.
Quantitative real-time RT-PCR
Fourteen days after cotransfection of HeLa cells with
pJM101/L1RPneo and either SVA retrotransposition
reporter plasmid or pCEPneo, total RNA was extracted
from hygromycin-selected HeLa cells using TRIZOL
(Invitrogen) following the manufacturer’s instructions.
One microgram of total RNA was incubated with 2U of
RNAse-free DNaseI (Invitrogen) for 30min at room tem-
perature. Using the SuperScript III First-Strand
Synthesis System for RT–PCR (Invitrogen) in combin-
ation with an oligo(dt)16–18 primer, ﬁrst-strand cDNA
was synthesized from 0.5 mg of DNaseI-digested, total
RNA according to the manufacturer’s instructions. To
quantify levels of spliced transcripts expressed from
the mneo-tagged reporter elements in pAD3/SVAE,
pAD4/SVAE, pSC3/SVAF1, pSC4/SCAF1 and pCEPneo,
real-time PCR was performed in triplicate applying
TaqMan chemistry (Applied Biosystems) in an Applied
Biosystems 7900HT Fast Real-Time PCR System base
unit. We used a primer /probe combination (Neofor:
50-GCTATTCGGCTATGACTGG-30; Neorev: 50-GCCA
CGATAGCCGCGCTGC-30; probe: 50-FAM-CCTCGTC
CTGAAGCTCATTC-30) speciﬁcally recognizing the
spliced mneoI cassette. For normalization, eukaryotic
18srRNA was used as internal control. Cycling conditions
were as follows: 95C for 15min (initial cycle), 95C for
15 s and 60C for 1min (40 cycles). The software applied
to analyze real-time and end point ﬂuorescence was RQ
manager 1.2. Relative quantiﬁcation of RNA expression
was carried out using the Ct method (30).
Immunoblot analysis
To assess L1 ORF1p and L1 ORF2p expression, HeLa
cells were cotransfected as described above and harvested
14 days (with hygromycin selection) or 2 days later
(without hygromycin selection), respectively. Cells were
lysed in RIPA buffer (25mM Tris, pH 8, 137mM NaCl,
1% glycerol, 0.5% sodium deoxycholate, 1% Nonidet
P-40, 2mM EDTA, pH 8, 0.1% SDS and protease inhibi-
tors), and lysates were cleared by centrifugation. In the
case of transient cotransfection of SVA reporter plasmid
and L1 protein donor, 2.8 106 cells were plated on 15-cm
dishes and transiently cotransfected as described above.
Cells of one 15-cm dish carrying the respective plasmids
were trypsinized 2 days after cotransfection and lysed with
RIPA lysis buffer. Twenty micrograms of each protein
lysate were boiled in Laemmli buffer, loaded on 12%
polyacrylamide gels, subjected to SDS–PAGE, and
electroblotted onto nitrocellulose membranes. After
protein transfer, membranes were blocked for 2 h at
room temperature in a 10% solution of non-fat milk
powder in 1 PBS-T [137mM NaCl, 3mM KCl,
16.5mM Na2HPO4, 1.5mM KH2PO4, 0.05 % Tween 20
(Sigma)], washed in 1 PBS-T, and incubated overnight
with the respective primary antibody at 4C. To detect L1
ORF1p, the polyclonal rabbit-anti-L1ORF1p antibody
#984 (see Supplementary Data) was used in a 1:2000
dilution in 1 PBS-T containing 5% milk powder. L1
ORF2p expression was veriﬁed using a rabbit anti-
ORF2p-N antibody (31) at a 1:1000 dilution in 1 PBS,
5% milk powder, 0.05 % Tween 20. Membranes were
washed thrice in 1 PBS-T and incubated with an HRP-
conjugated, secondary anti-rabbit IgG antibody
(Amersham Biosciences) at a dilution of 1:30 000 in 1
PBS-T/5% milk powder for 2 h. Subsequently, the
membrane was washed three times for 10min in 1
PBS-T. ß-actin and a-tubulin expression were detected
using a monoclonal anti-b-actin antibody (clone AC-74,
Sigma-Aldrich) and a polyclonal anti-a-tubulin antibody
(ab4074, Abcam) as primary antibodies at dilutions of
1:30 000 and 1:10 000, respectively. Anti-mouse HRP-
linked species-speciﬁc antibody (from sheep) at a dilution
of 1:10 000 and anti-rabbit HRP-linked speciﬁc antibody at
a dilution of 1:5000 served as secondary antibodies speciﬁc
for anti-b-actin and anti-a-tubulin antibody, respectively.
Immunocomplexes were visualized using lumino-based
ECL immunoblot reagent (Amersham Biosciences).
Analysis of SVA de novo insertions
Genomic DNA from expanded G418R -HeLa colonies
was isolated applying the Qiagen DNeasy Tissue Kit
according to the manufacturer’s protocol. To test for the
Figure 1. Continued
SINE-R 30-end and mneoI cassette. Transcriptional termination signals (AATAAA) at the SINE-R 30-end and in the sequence ﬂanking the 30 TSD
of AluSp were omitted from the inserted SVA retrotransposition cassettes to ensure transcriptional read-through into the mneoI cassette and
polyadenylation at the pCEP4-encoded SV40 polyadenylation signal (pA). pCEPneo is distinguished from the SVA reporter elements by the
absence of any SVA sequence. CMVP sequences are highlighted in grey. CMVP major and minor transcription start sites (47) are indicated by
arrows. Black rectangles, Alu TSDs; (B) Experimental setup to test for trans-mobilization of mneoI-tagged SVA elements by the L1 protein
machinery. Approach 1: Hygromycin selection for the presence of SVA reporter and L1 protein expression plasmid. SVA retrotransposition
reporter plasmids or pCEPneo were each cotransfected with L1 protein donor pJM101/L1RPneo or pJM101/L1RPneoORF1 into HeLa cells
which were subsequently selected for hygromycin resistance for 14 days. Resulting cell populations were assayed for retrotransposition events by
selecting for 9–12 days for G418R HeLa colonies. Approach 2: Transient cotransfection of SVAE reporter plasmids and L1 protein donor plasmid
pJM101/L1RPneo with subsequent G418
R selection. Two days after cotransfection of SVA reporter plasmids or pCEPneo and pJM101/L1RPneo,
HeLa cells were assayed for L1-mediated trans-mobilization of the respective reporter cassette by selection for G418 resistance.
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presence of the spliced mneoI indicator cassette, a diag-
nostic PCR was performed using the intron-ﬂanking
primer pair GS86/GS87 (Figure 4 and Supplementary
Table S1). PCR cycling conditions were as follows:
3min at 96C, (30 s at 96C, 15 s at 56C; 2min at 72C)
25 cycles, 7min at 72C. To determine genomic pre- and
post-integration sites of SVA de novo insertions, we used a
modiﬁed version (32) of a previously published extension
primer tag selection preceding solid-phase ligation-
mediated PCR (EPTS/LM-PCR) (33) to isolate 30 junc-
tions of these insertions. Products of the ﬁnal PCR were
separated in a 1% agarose gel, isolated from the gel using
the QIAquick Gel Extraction Kit (Qiagen), and sequenced
either directly or after subcloning into pGEM-T Easy.
Obtained sequences were mapped to the human genome
using the UCSC genome browser at http://genome.ucsc
.edu. To characterize 50-junctions of each SVA de novo
insertion, primers speciﬁc for the genomic sequence
adjacent to the 50-end of the de novo insertions were
designed. The second PCR primer used was GS87, GS88
or, alternatively, HERV-K REV because these primers
bind speciﬁcally to the retrotransposed SVAE reporter
cassette. All oligonucleotides used in this study are listed
in Supplementary Table S1. Genomic pre-integration sites
and surrounding sequences were characterized using
the UCSC genome browser annotation for genes, the
Repeatmasker and G+C content tracks. For localization
of the integration sites to particular isochores/
G+C-content regions the table published by Costantini
et al. (34) was used.
Sequence logos
To display patterns of sequence conservation between
genomic target sequences of pre-existing SVAE/SVAF,
L1-Ta and AluYa5 elements and isolated SVAE de novo
retrotransposition events, sequence logos were generated
(Figure 6) applying the program WebLogo (35, http://
weblogo.berkeley.edu/logo.cgi). We randomly picked 70
genomic target sequences of preexisting members from
each of the retrotransposon subfamilies L1Hs-Ta,
AluYa5 and SVAE or SVAF. Genomic target sequences
of L1Hs-Ta and AluYa5 elements (Supplementary Table
S3) were identiﬁed from databases (L1_selection.xls;
L1_TSD.txt; L1_coord_seq.txt; http://batzerlab.lsu.edu)
published recently (36,37). Genomic target sequences
of 70 preexisting members of the SVA subfamilies E and
F (Supplementary Table S3) were determined from
a recently published list of human endogenous SVA
insertions (21).
RESULTS
Identiﬁcation, isolation and engineering of functional
human-speciﬁc SVA reporter elements
In order to test the hypothesis that SVA elements are
mobilized by the L1-encoded protein machinery, we set
out to establish a trans-mobilization assay in which
potentially functional marked SVA elements are tested
for retrotransposition in the presence of the overexpressed
L1 protein machinery. As a ﬁrst step we identiﬁed
human-speciﬁc, genomic SVA elements that were likely
to be retrotransposition-competent (RC). Since sequence
and/or structural characteristics of RC SVA source
elements were unknown and RC SVA source elements
had not been identiﬁed when we started our study,
we ﬁrstly selected SVA insertions reported earlier to be
the cause of single cases of genetic disorders. These
SVAs were caught red-handed after they were launched
from RC source elements and did not have time to accu-
mulate disﬁguring mutations in the human genome.
We picked the sequence of an SVAE insertion into the
LDLRAP1 gene that caused a case of autosomal recessive
hypercholesterolemia (ARH) (26), as query, and per-
formed a BLAT search of the human genome reference
sequence (hg17; May 2004) to identify the potential source
element of the disease-causing insertion. We observed
100% identity between the query sequence and genomic
SVAE element H19_27 (Supplementary Figure S1) which
displays presence/absence polymorphism in the human
genome (21). Given the sequence correlation between the
ARH-causing SVA insertion and SVA H19_27, and the
polymorphic state of H19_27, we concluded that either
H19_27 is the source element of the disease-causing SVA
insertion, or both H19_27 and the ARH-causing insertion
are derived from the same source element which is
not present in the analyzed human genome reference
sequence. Therefore, we chose the SVAE element
H19_27 as a reporter element for the planned SVA
retrotransposition reporter assays. To generate the SVA
retrotransposition reporter plasmid pAD3/SVAE, the
genomic canonical SVAE element H19_27 was ampliﬁed
by PCR, tagged at its 30-end with the mneoI indicator
cassette (38), and inserted into the episomal pCEP4
expression vector, where the SVA reporter cassette was
set under the control of the human CMV promoter
(Figure 1A; see ‘Materials and Methods’ section). To
address the question if the (CCCTCT)n repeats and/or
the 300-bp Alu-like region at the 50-end of SVA elements
play a role in the efﬁciency of any potential trans-
mobilization of SVA elements, we deleted 498 nt of the
50-end sequence of the SVA element in pAD3/SVAE to
generate pAD4/SVAE (Figures 1 and Supplementary
Figure S1).
We chose the genomic SVAF1 element H10_1 as second
retrotransposition reporter, because it has been identiﬁed
recently as source element of at least 13 SVAF1 subfamily
members (21,23), including one SVAF1 element that is the
progenitor of a disease-associated insertion into the
HLA-A gene (39). The human-speciﬁc SVAF1 subfamily
was generated by the acquisition of a MAST2 sequence
via splicing (21,23), includes at least 84 elements and has
further evolved by usurping 50- and 30-transductions that
include Alu sequences. We PCR-ampliﬁed SVA H10_1
together with its 30-ﬂanking functional AluSp element
from a BAC clone because it was shown that, due to the
weak transcriptional termination signal at the 30-end of
the SINE-R module, transcriptional readthrough into
the 30-ﬂanking genomic AluSp sequence can occur (21)
(Figure 1A). Termination of Pol II transcription by a
termination signal located downstream of the AluSp
TSD caused 30-transducing H10_1 transcripts that
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were retrotransposed, leading to at least 13 genomic
30-transduced SVAF1 insertions (21).
Since there is evidence that both the H10_1 element
alone and H10_1 derivatives including the 30-transduced
AluSp sequence have served as source elements for SVA
retrotransposition (21,23), we tested both SVAF1 members
(Figure 1A; pSC3/SVAF1, pSC4/SVAF1) in our trans-
mobilization assay.
For that purpose, we ﬁrst fused the entire 3.5-kb H10_1
element at its SINE-R 30-end with the mneoI indicator
cassette in opposite orientation, and inserted the marked
SVAF1 reporter element into the pCEP4 expression vector,
generating pSC3/SVAF1 (Figure 1A). Next, we fused the
genomic AluSp element to the 30-end of SVA H10_1,
which resulted in a structure that also constitutes the
genomic situation. The fusion was tagged with the mneoI
indicator cassette and the entire 6.2-kb retrotransposition
reporter cassette was inserted into pCEP4, resulting in
pSC4/SVAF1 (Figure 1A). To ensure that the indicator
cassette is transcribed as efﬁciently as the upstream SVA
sequences, transcriptional termination signals located at
the SINE-R 30-end and in the sequence downstream
of the AluSp 30 TSD were removed (AATAAA;
Figure 1A). Since pSC3/SVAF1 and pSC4/SVAF1 differ
exclusively in the presence of an intact AluSp element at
the SINE-R 30-end, we will be able to evaluate if this
element plays any role in SVA trans-mobilization
efﬁciency.
L1-encoded proteins facilitate retrotransposition of both
SVAE reporter elements
To evaluate if the SVAE reporter elements are trans-
mobilized by the L1-encoded protein machinery, we
cotransfected pAD3/SVAE and pAD4/SVAE with the L1
protein donor plasmid pJM101/L1RPneo or pCEP4 into
HeLa-JVM cells (Figure 1B) because it was demonstrated
that HeLa cells can efﬁciently accommodate and express
proteins from two different expression vectors (2).
Cotransfected cells were subjected to hygromycin selection
for the presence of the plasmids (Figure 1B) and
subsequently selected for G418 resistance. Each SVA
reporter element was tagged with an antisense copy of
the selectable marker gene neo encoding neomycin
phosphotransferase, a heterologous promoter (P0), and a
polyadenylation signal (A0) (Figure 1A). This arrangement
ensures that G418-resistant cells (G418R) will only arise if
a transcript initiated from the human CMV promoter
(CMVP) driving SVAmneoI or CEPmneoI expression is
spliced, reverse transcribed, reintegrated into chromosom-
al DNA, and expressed from promoter P0. G418R foci
indicating retrotransposition of an SVA reporter
cassette, could be observed only if the L1 expression
plasmid was cotransfected suggesting that L1 proteins
are required for SVA mobilization (Figures 2A and
Supplementary Figure S3).
Next, we asked if L1 proteins prefer our reporter SVA
mRNA to any other PolII transcript as substrate for trans-
mobilization. If this was the case, trans-mobilization
frequency of the SVA reporter element would be
expected to exceed the frequency of processed pseudogene
formation of a regular PolII gene. In order to determine
the pseudogene formation rate, we generated the reporter
plasmid pCEPneo which differs from pAD3/SVAE ex-
clusively by the absence of the 1876-bp SVA sequence
(Figure 1A). Since transcripts expressed from the CMVP
of pCEPneo consist exclusively of the mneoI indicator
cassette in antisense orientation and do not include any
retrotransposon sequences, these transcripts should be
trans-mobilized as frequent as random mRNAs encoded
by host PolII genes. Overall, trans-mobilization
frequencies of the pAD3/SVAE-encoded canonical SVA
element exceeded pseudogene formation of the reverse
mneoI cassette by 2- to 5-fold whereas the 50-truncated
SVAE cassette encoded by pAD4/SVAE outnumbered
the pseudogene formation rate by only 1- to 3-fold
(Figures 2A and Supplementary Figure S3). While the dif-
ferences in trans-mobilization rates between pAD3/SVAE
and pCEPneo were statistically signiﬁcant (p1=0.0001),
those between pAD4/SVAE and pCEPneo were not
(p2=0.2212). To verify that the observed differences in
trans-mobilization rates between pAD3/SVAE and pAD4/
SVAE are not resulting from discrepancies in mRNA pro-
duction or stability between the different SVA reporter
constructs, we tested for the presence of similar amounts
of spliced, tagged SVA mRNAs by quantitative real-time
RT–PCR (qRT–PCR) (Figure 2B). Using primer/probe
combinations speciﬁcally recognizing the spliced mneoI
reporter cassette, we quantiﬁed the relative amounts of
spliced mRNA expressed from the reporter plasmids
after 14 days of hygromycin selection (Figure 2B).
Clearly, the observed differences in the amounts of
spliced SVA reporter mRNA of 1.1-fold between pAD3/
SVAE- and pAD4/SVAE-tranfected cells (Figure 2B) is
only minor compared to the 2- to 5-fold differences in
trans-mobilization rates (Figure 2A). Therefore, we draw
the conclusion that the 498-nt fragment deleted from the
50-end of the canonical SVA element in pAD3/SVAE
makes the 50-truncated element in pAD4/SVAE a
somewhat less attractive substrate for trans-mobilization.
Interestingly, although the amount of spliced pCEPneo
transcripts exceeds those derived from transcription of
the SVAE reporter cassettes, trans-mobilization of SVAE
transcripts is still more efﬁcient, emphasizing that SVAE
RNA is a preferred substrate for the L1 protein machin-
ery. In order to evaluate if the observed differences in
trans-mobilization rates can be attributed to varying L1
protein levels, we assessed L1 ORF1p and ORF2p expres-
sion in a parallel set of cotransfected hygR -selected HeLa
cell cultures (Figure 2C). Immunoblot analysis of cell
extracts isolated the day before the onset of G418 selection
of the remaining cotransfected cultures, shows that com-
parable amounts of ORF2p are expressed in the different-
ly cotransfected cells. Although L1 ORF1p levels are
elevated in HeLa cells cotransfected with pCEPneo
relative to pAD3/SVAE- and pAD4/SVAE-cotransfected
cells, the observed trans-mobilization rate is the highest
in cells cotransfected with pAD3/SVAE. This indicates
that the observed differences between pseudogene forma-
tion rate and SVAE trans-mobilization frequencies did not
result from diverse L1 protein levels.
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Figure 2. Trans-mobilization of mneoI-tagged SVAE reporter elements. (A) SVAE retrotransposition reporter assay after hygromycin selection for the
presence of expression plasmids. SVAE reporter plasmids pAD3/SVAE, pAD4/SVAE, or pCEPneo were cotransfected with the L1 protein donor
pJM101/L1RPneo (L1RP) or the empty vector pCEP4. After hyg
R selection, G418R selection for retrotransposition events followed and retrotran-
sposition rates were determined by counting G418R HeLa colonies. Each cotransfection experiment and subsequent retrotransposition reporter assay
was carried out three times in triplicates. Retrotransposition frequencies per 106 cells are listed and relative retrotransposition rates are indicated as
bar diagram. Cis retrotransposition rate of the L1 reporter element pJM101/L1RP was set as 100%. Each bar depicts the arithmetic mean ± SD of
the relative retrotransposition rates obtained from nine individual cotransfection experiments (n= 9). (B) qRT–PCR analyses to quantify the relative
amounts of spliced transcripts expressed from retrotransposition reporter cassettes. Total RNA was isolated 48 h after cotransfection of pCEPneo,
pAD3/SVAE, and pAD4/SVAE with the L1 protein donor plasmid pJM101/L1RPneo. The used primer/probe combination (see ‘Materials and
Methods’ section) is speciﬁc for the spliced mneoI-cassette (black box with arrow). Relative amounts of mRNA expression refer to the signal
obtained from total RNA of untransfected HeLa cells which was set as 1 (C1); Total RNA from mock-transfected HeLa cells served as negative
control. (C) Immunoblot analysis of L1 protein expression in HeLa cells after cotransfection of the L1 protein donor (L1RP) with retrotransposition
reporter plasmids pAD3/SVAE, pAD4/SVAE and pCEPneo. Whole-cell lysates were prepared 14 days after cotransfection upon completion of
hygromycin selection and subjected to immunoblot analysis using antibodies against either L1 ORF1p (aORF1p) or L1 ORF2p (aORF2p).
An amount of 20 mg of whole-cell extracts were loaded per lane. a-tubulin protein levels (50 kDa) were analyzed as loading control. Lysates
from untransfected HeLa cells and from the germ cell tumor cell line NTera-2 served as negative and positive control for L1 protein detection,
respectively. (D) SVAE trans-mobilization assay after transient cotransfection of expression plasmids. pAD3/SVAE, pAD4/SVAE or pCEPneo were
transiently cotransfected with pJM101/L1RPneo (L1RP) or pCEP4 into HeLa cells. Two days later, cells were G418-selected for de novo retrotran-
sposition events for 14 days. G418R HeLa colonies were Giemsa-stained and counted. Each cotransfection experiment was done in quadruplicate.
Subsequent retrotransposition reporter assays were performed in triplicate. Retrotransposition frequencies per 106 cells are listed and relative
retrotransposition rates are indicated as bar diagram. Cis retrotransposition rate of L1 reporter element pJM101/L1RP was set as 100%.
Each bar depicts the arithmetic mean ± SD of the relative retrotransposition rates obtained from three individual cotransfection experiments (n=3).
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Next, we wanted to evaluate if we can conﬁrm these
results on trans-mobilization of the SVAE reporter
elements in an experimental setup, in which we transiently
cotransfect HeLa cells with retrotransposition reporter
and L1 protein donor plasmid, and select for retrotran-
sposition events 2 days later (Figure 1B, approach 2).
In compliance with the results obtained in the case of
approach 1, we observed in this transient-cotransfection
setup trans-mobilization rates of the SVA reporter cas-
settes in pAD3/SVAE and pAD4/SVAE which exceeded
pseudogene formation rates by 2- to 5-fold (arithmetic
mean: 3.5-fold) and 1- to 3-fold (arithmetic mean:
2.4-fold), respectively (Figure 2D). Again, the difference
in trans-mobilization rates between pAD3/SVAE and
pCEPneo was statistically signiﬁcant (p3=0.0021),
whereas differences between pAD4/SVAE and pCEPneo
were not (p2=0.0354). To test for comparable expression
levels of the L1 protein machinery, we assessed L1 ORF1p
expression in a parallel set of transiently cotransfected
HeLa cultures. Immunoblot analysis of cell lysates
harvested three days after cotransfection uncovered that
there were no detectable differences in L1 ORF1p expres-
sion levels between the differently cotransfected cells
(Supplementary Figure S5). This conﬁrms that also in
the transient-cotransfection setting, the observed
discrepancies in trans-mobilization rates (Figure 2D and
Supplementary Figure S4) are not a consequence of
varying expression levels of the L1 protein machinery.
The 30-transduced AluSp element increases the
trans-mobilization rate of the SVAF1
source element by 25-fold
In order to evaluate if the canonical SVAE reporter
element differs in its trans-mobilization rate from SVAF
elements that were reported to be source elements of the
highly successful human-speciﬁc SVAF1 subfamily,
we tested pAD3/SVAE, pSC3/SVAF1 and pSC4/SVAF1
(Figure 1) in our trans-mobilization assay in parallel.
Cotransfection of pAD3/SVAE, pSC3/SVAF1 and
pCEPneo with the L1 protein donor plasmid pJM101/
L1RPneo into HeLa-HA cells uncovered that SVAE
reporter and SVAF1 source element H10_1 are trans-
mobilized by 18 and 12-fold relative to pseudogene
formation rate, respectively (Figure 3A and B).
Surprisingly, the mobilization rate of the pSC4/SVAF1-
encoded SVAF1 source element that includes the
30-transduced AluSp sequence was exceeding pseudogene
formation rate by 300-fold. This corresponds with
a relative retrotransposition rate of 11% of L1 cis
activity (Figure 3A and B). Data suggest that the
acquired AluSp sequence makes the SVA element a sig-
niﬁcantly more attractive substrate for the L1 protein
machinery resulting in a mobilization rate that corres-
ponds to AluY reporter elements (3).
SVA trans-mobilization requires both L1 ORF1p
and L1 ORF2p
While it is obvious that the generation of G418R foci
after expression of the L1 protein machinery requires
ORF2-encoded RT activity, it was unclear if L1 ORF1p
is essential for SVA trans-mobilization. To uncover,
if L1 ORF1p is required for trans-mobilization of
SVA elements, we generated a second L1 protein donor
plasmid, termed pJM101/L1RPneoORF1, which
differs from pJM101/L1RPneo exclusively in a 330-bp
in-frame deletion in L1 ORF1 (Figure 1B). The in-frame
deletion of pJM101/L1RPneoORF1 ensures that an
ORF1p mutant which lacks amino acid positions 99–208
is expressed, and that initiation of ORF2 translation
within the bicistronic RNA is not perturbed. The
deletion comprises the C-terminal half of the coiled coil
(cc) domain and the N-terminal half of the
RNA-recognition motif (RRM) domain of ORF1p (40).
We conﬁrmed by immunoblot analysis that both L1
protein donor plasmids facilitated expression of similar
amounts of ORF2p after cotransfection with each of the
three SVA reporter plasmids (Figures 3C). Coexpression
of ORF1p deletion mutant and functional ORF2p
from pJM101/L1RPneoORF1 did not result in trans-
mobilization of the SVA reporter elements encoded by
pAD3/SVAE and pSC3/SVAF1 indicating that an intact
ORF1p is essential for SVA retrotransposition.
Surprisingly, in the absence of both overexpressed L1
proteins or ORF1p alone, trans-mobilization of the
SVAF1 reporter element of pSC4/SVAF1 was still exceed-
ing pseudogene formation by 2- to 3-fold (Figure 3A).
Since the 30-transduced AluSp sequence obviously makes
the SVA RNA a preferred substrate for L1 proteins, mo-
bilization in the absence of overexpressed L1 proteins
could be explained by trans-mobilization of the pSC4/
SVAF1 reporter cassette beyond pseudogene formation
by the moderately expressed endogenous L1 protein
machinery in HeLa cells (41,42). Quantiﬁcation of
spliced SVA reporter RNAs by qRT–PCR (Figure 3D)
and of overexpressed L1 proteins by immunoblot
analysis (Figure 3C) show that the observed differences
in G418R colonies are neither a consequence of differences
in the amounts of spliced retrotransposition reporter tran-
scripts nor the result of varying amounts of overexpressed
L1 proteins.
Structural features of SVA de novo integrants
To verify that the G418R HeLa colonies that resulted from
SVA trans-mobilization assays were a consequence of
marked SVA de novo retrotransposition events, genomic
DNA was extracted from 12 randomly chosen single
expanded G418R HeLa cell colonies which had resulted
from cotransfection of the SVAE reporter plasmids with
pJM101/L1RPneo (Figure 2A). First, we carried out
a diagnostic PCR on genomic DNA with primers
spanning the intron of mneoI (Figure 4). The generation
of a 792-bp PCR product shows that transcription,
splicing, and L1-mediated reverse transcription of the
SVA reporter elements as well as integration of the
SVAE-mneoI cDNA into the genome has occurred.
A 1694-bp PCR product that would be speciﬁc for the
unspliced indicator cassette encoded by the SVAE
retrotransposition reporter plasmids could not be
detected (Figure 4). Since PCR products obtained from
HeLa clone X differed from the expected pattern, this
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Figure 3. L1 ORF1p is required for trans-mobilization of SVA reporter elements. (A) Trans-mobilization of SVAE and SVAF1 reporter elements in
presence/absence of the entire L1 protein machinery. SVA reporter plasmids pAD3/SVAE, pSC3/SVAF1 and pSC4/SVAF1 were each cotransfected
with intact (L1RP) and mutant (ORF1) L1 protein donor plasmid and pCEP4. pCEPneo was cotransfected with pJM101/L1RPneo (L1RP) or the
empty vector pCEP4. After hygR selection, cotransfected HeLa cells were G418-selected for retrotransposition events and retrotransposition rates
were determined. Each cotransfection experiment and subsequent retrotransposition reporter assay was carried out in triplicates twice (n= 6).
Retrotransposition rates per 106 cells including standard deviations (±SD) are listed. Arithmetic means of mobilization rates relative to the cis-
activity of pJM101/L1RP (L1 cis activity) are speciﬁed and depicted as bar diagram. Error bars,±SD; Primary data of trans-mobilization assays are
summarized in Supplementary Figure S6. (B) The 30 terminal AluSp sequence of SVAF1 element H10_1 increases its trans-mobilization rate by
25-fold. For reasons of clarity, a subset of the information presented in Figure 3A is displayed. Relative retrotransposition rates (L1 cis activity
[%]) and retrotransposition frequencies that resulted from cotransfections with the L1 protein donor pJM101/L1RP (L1RP) are compared. (C)
Immunoblot analysis of L1 protein expression after cotransfection of L1 protein donors with SVA retrotransposition reporter plasmids or
pCEPneo. Whole-cell lysates were prepared 14 days after cotransfection upon completion of hygromycin selection and subjected to immunoblot
analysis using antibodies against either L1 ORF1p (aORF1p) or L1 ORF2p (aORF2p). An amount of 70 mg of whole-cell lysates were loaded per
lane. a-tubulin protein levels (50 kDa) were analyzed as loading control. Lysates from untransfected HeLa cells and from the germ cell tumor cell
line 2102Ep served as negative and positive control for L1 protein detection, respectively. Shorter (exp.1) and longer exposures (exp.2) of the
aORF1p immunoblot are presented to demonstrate expression of endogenous L1 ORF1p. (D) qRT–PCR analyses to quantify relative amounts of
spliced transcripts encoded by the diverse retrotransposition reporter cassettes. Total RNA was isolated after 14 days of hygromycin selection
following cotransfection of the reporter constructs pSC3/SVAF1, pSC4/SVAF1 and pCEPneo with pJM101/L1RPneo. The used primer/probe
combination is speciﬁc for the spliced mneoI-cassette (Figure 2B). Relative amounts of mRNA expression refer to the signal obtained from total
RNA of untransfected HeLa cells which was set as 1 (C1); Total RNA from mock-transfected HeLa cells served as negative control.
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clone was excluded from further analyses. Next, we
examined the structures of the genomic mneo-tagged
SVAE de novo insertions for attributes of L1-mediated
retrotransposition. Analysis of pre- and post-integration
sites of eight pAD3/SVAE-derived and three pAD4/SVAE-
derived de novo insertions isolated from G418R HeLa
colonies (Figure 5) revealed that 5/11 insertions occurred
into genes (Supplementary Table S2) and each insertion
is indeed distinguished by structural hallmarks of
L1-mediated retrotransposition such as a 30- to 78-nt
poly(A) tail. The nucleotide proﬁle of the target sites of
SVAE de novo insertions resembles the L1 EN consensus
target sequence 50-TTTT/AA-30 of L1-Ta de novo inser-
tions and preexisting L1-Ta, AluYa5 and SVAE/F inser-
tions (Figure 6). This indicates that the sequence
speciﬁcity of L1 EN determines SVA integration site
properties at the local level. With one exception, all
characterized insertions are ﬂanked by TSDs ranging
from 8 to 19 nt (Figure 5). SVA de novo insertion 9 led
to the formation of an 11-bp target site deletion, and
the deleted sequence was replaced by a 50-truncated
mneoI-tagged SVA retrotransposition event lacking
TSDs. The formation of similar genomic target site
deletions ranging from 1 bp to >11 kb associated with
50-truncated de novo insertions has been reported
for EN-dependent L1 retrotransposition events earlier
(43–45). Target site deletions associated with
L1-mediated retrotransposition events are believed to
arise as a consequence of a second-strand cleavage event
that occurred upstream of the initial ﬁrst-strand cleavage
(43,46).
Only 2 out of the 11 characterized SVA de novo inser-
tions were characterized by 50-truncations encompassing
1716 and 680 bp (insertions 6 and 9; Figure 5), respective-
ly. The remaining nine insertions are full-length and
cover 3347 (pAD3/SVAE-derived) and 2850 nt (pAD4/
SVAE derived). The 5
0-ends of SVA full length de novo
insertions derived from both SVA reporter elements
coincide with positions 3 or 4 downstream of the CMV
promoter transcription initiation site (47) indicating that
transcription of the SVA reporter elements is controlled
by CMVP and not by any potential SVA-speciﬁc internal
promoter. Full-length SVA de novo insertions include the
same 44–45 nt of non-SVA sequences at their 50-ends
which result from transcriptional initiation within the
CMVP region (Figure 1A).
In three cases we observed an untemplated G nucleotide
between the 30-end of the 50 TSD and the 50-end of
full-length SVA insertions. (Figure 5A; insertions 2, 5
and 8). We identiﬁed short patches of microcomple-
mentarity of 1–2 nt at the 50-genomic DNA/SVA
junction of 5/11 SVA de novo insertions which is consist-
ent with previous studies analyzing preexisting 50-genomic
DNA/L1 junctions (48,36) and 50-junctions of L1 de novo
insertions (44,45). Taken together, each of the described
structural features of SVA de novo insertions have been
reported for L1 de novo insertions before. This is
indicating that the analyzed SVA de novo insertions are
a consequence of the trans-activity of the L1 protein
machinery acting on SVA transcripts.
Target site preferences of de novo SVA integrants
SVA de novo insertions showed a clear integration prefer-
ence for TSDs or sequences ﬂanking endogenous
non-LTR retrotransposons. Five out of the 11 charac-
terized SVA insertions occurred into Alu-TSDs or
adjacent sequences (Figure 5). SVA copies inserted into
an L1 30-end (insertion 10) and within the ﬁrst 100 nt of
the 30-ﬂanking region of an L1 element (insertion 5),
respectively.
We calculated the average G+C content of the genomic
sequences ﬂanking de novo SVA insertion within 5-kb
windows and 30-kb windows, and found that it
amounted to 44% and 44.2%, respectively (Table 1).
This was signiﬁcantly higher than the genome average of
41% (p5kb< 0.025; p30kb< 0.005), and is in accordance
with the overall distribution of preexisting members of
the SVA subfamilies E and F which were reported to
have accumulated in G+C-rich regions of the human
genome (12). Several scenarios have been proposed for
the apparent enrichment of SVAE and SVAF elements in
G+C-rich regions (12). Sequence analyses of the 5-kb and
30-kb windows also indicate that SVA de novo insertions
occurred into genomic regions with an increased Alu
density and a relatively poor L1 density compared to the
overall genomic situation (Table 1). Distribution of SVA
de novo insertions to different isochores/ G+C-content
domains of the genome is consistent with the recently
Figure 4. Diagnostic PCR to test for correct splicing of the intron from the mneoI indicator cassette. Genomic DNA was extracted from 12 G418R
HeLa clones that have resulted from cotransfection of pAD3/SVAE (clones 1–8, X) or pAD4/SVAE (clones 9–11) with pJM101/L1RPneo and
subsequent hygromycin selection. The DNAs were used as template for PCR with primers GS86 and GS87. The PCR allows distinction of the spliced
and reverse-transcribed form of the mneoI cassette (792-bp PCR product) from the original unspliced form (1694-bp PCR product) present in
the reporter constructs and conﬁrmed integration into the genome via authentic retrotransposition (29). As positive control for an unspliced neoR
gene, PCR was performed on pSV2neo (BD Biosciences) mixed with genomic DNA from untransfected HeLa cells (lane C1). PCR performed on
pJM101/L1RP DNA that was mixed with genomic HeLa DNA resulted in a fragment speciﬁc for the unspliced neo
R cassette (lane C2). Lane M, 1-kb
Plus DNA ladder (Invitrogen).
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Figure 5. Genomic SVAE de novo insertions display hallmarks of L1-mediated retrotransposition. Both pre- and post-integration sites are presented.
Insertions 1–8 and 9–11 are derived from SVAE reporter elements encoded by pAD3/SVAE and pAD4/SVAE, respectively. Nucleotide positions at
the 50-end of each SVA insertion refer to the reference sequence of SVA H19_27 [(21); Supplementary Figure S1]. Marked full-length insertions cover
3.3 kb (pAD3/SVAE-derived) and 2.8 kb (pAD4/SVAE-derived), respectively. Identiﬁed 50-truncated insertions comprise 1580 bp (insertion 6) and
1620 bp (insertion 9), respectively. The L1EN cleavage site on the bottom strand is indicated in blue. Extra deoxyguanylates at the 50-ends of de novo
insertions are indicated in green. CMVP-derived sequences are highlighted in yellow. Nucleotides representing patches of microcomplementarity are
underlined. Black bars, Alu TSD sequences. Red lettering, SVA TSD sequences; neo, neomycin-phosphotransferase gene.
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described situation of genomic SVA copies (49). Eight
integrants are found in isochore H1, while the remainder
insertions are located in isochore L2 (two insertions) and
H2 (one insertion).
DISCUSSION
L1-mediated trans-mobilization of SVA elements requires
both L1 encoded proteins
In order to gain insight into the molecular mechanisms of
the mobilization of the non-autonomous SVA elements,
we tested the hypothesis that SVA elements are trans-
mobilized by the protein machinery encoded by functional
L1 elements. We established an SVA retrotransposition
reporter assay which enabled us to experimentally
conﬁrm that SVA RNA recruits the L1 protein machinery
for its own mobilization. Trans-mobilization frequencies
of the tested human-speciﬁc SVA reporter elements
exceeded the processed pseudogene formation rate of
cellular mRNAs by 2- to 5-fold in HeLa-JVM cells and
by 12- to 300-fold in HeLa-HA cells. During the revision
of this manuscript, Hancks and coworkers published in
rough accordance with our results that, in their hands,
Figure 6. The nucleotide proﬁle of SVAE de novo insertion sites resembles the consensus target sequence of pre-existing human-non-LTR retro-
transposons. Target sequence logos were generated by multiple sequence alignments of genomic integration sites of L1Hs-Ta, AluYa5, SVAA and
SVAE insertions using the program WebLogo (35). Logos for the top strand sequence cover four nucleotides of upstream and eight nucleotides of
downstream sequences relative to the L1 EN cleavage site (arrow) on the bottom strand. Numbers denote nucleotide positions relative to the nicking
site. (A) Comparison of consensus target sequences of L1 and SVAE de novo insertions. Target sequence logos were generated for SVA de novo
integration sites (n= 11) and for target sequences of 35 L1 de novo insertions (43). (B) Target sequence logos of 70 preexisting L1-Ta, AluYa5 and
SVAE/F insertions. Integration site sequences were identiﬁed as described in the ‘Material and Methods’ section.
Table 1. G+C- and retrotransposon content of genomic sequences ﬂanking SVA de novo insertions
SVA insertion G+C 5kb (%) Alu 5 kb (%) L1 5 kb (%) G+C 30kb (%) Alu 30 kb (%) L1 30 kb (%)
1 46.44 35.8 1.52 43.91 45.51 7.04
2 42.40 44.54 – 42.32 31.01 9.42
3 40.57 40.86 3.58 40.54 36.62 2.74
4 48.39 39.88 – 45.98 44.36 7.88
5 38.93 13.54 22.28 42.30 16.52 6.11
6 40.03 17.34 – 38.28 11.81 –
7 39.42 36.42 11.62 42.41 19.89 1.94
8 45.43 39.92 2.66 47.02 36.46 7.30
9 50.85 13.28 – 49.17 12.26 7.28
10 44.81 29.96 24.1 48.75 31.78 5.75
11 47.00 32.98 0.48 45.42 30.25 4.19
Arith. Mean 1–11 44.02 31.32 5.21 44.19 28.77 5.97
Genome average 40.91 10.60 16.89 40.91 10.60 16.89
Analyzed sequences encompass 5-kb and 30-kb windows; G+C 5kb/G+C 30kb, G+C content (in percent) of 5-kb or 30-kb genomic sequence
windows ﬂanking the SVA de novo insertions; Alu 5 kb/Alu 30 kb (L1 5 kb/L1 30 kb), fraction of Alu (L1) sequences (in percent) covering 5-kb or
30-kb genomic sequence windows ﬂanking the SVA de novo insertion.
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L1-mediated SVA retrotransposition exceeds processed
pseudogene formation in HeLa-HA cells by 1- to 54-fold
(50). We observed a strict requirement of L1 ORF1p and
L1 ORF2p for the mobilization of the three tested SVA
reporter elements in HeLa cells. While ORF1p was also
shown to be essential for processed pseudogene formation
(2,7), it is dispensable for Alu retrotransposition (3).
The stern need for ORF1p for the mobilization of both
versions of the SVAF1 source element on chromosome
10 which differ from each other exclusively in the
presence/absence of the 390 bp AluSp 30 transduction
was conﬁrmed by Hancks et al. (50). However, while we
also observed the same requirement of ORF1p for the
mobilization of the canonical SVAE reporter element
H19_27, the Kazazian laboratory obtained conﬂicting
results when they analyzed the role of ORF1p in the
mobilization of a canonical SVAD source element (50):
Consistent with our ﬁndings, they reported that expression
of an L1 driver with a double mutation in the RRM
domain of ORF1p blocked trans-mobilization of the ca-
nonical SVAD source element almost entirely in HeLa-HA
cells, and that coexpression of ORF2p alone with the
EGFP-marked SVAD element led to barely any detectable
retrotransposition events. In contrast, coexpression of
ORF2p with the mneoI-marked SVAD element produced
more G418R foci than transfection with the intact
full-length L1 driver plasmid suggesting that ORF2p
alone is essential for trans-mobilization (50). It is
unlikely that the 600-bp difference in the extension of
the VNTR region between the 1.9-kb SVAE element and
the 2.5-kb SVAD element played any role in the
observed differences in ORF1p requirement.
Structural features of SVA elements affecting
trans-mobilization rates
The observation that the trans-mobilization rates of the
canonical SVAE reporter element in pAD3/SVAE exceeds
retropseudogene formation by 2- to 5-fold in HeLa-JVM
cells and by 18-fold in HeLa-HA cells, raises the
question if potential SVA-speciﬁc structural features
might qualify SVA transcripts as preferred substrates for
the L1 protein machinery. First, as indicated by Alus,
tRNA-derived SINEs (51), and tailless tRNAs, the
ability of an RNA to localize to the ribosome determines
its retrotranspositional success. After transcription, the
SVA RNA needs to come in contact with L1 ORF2p,
and out-compete the L1 RNA for the attention of
ORF2p. L1 and Alu RNA competition for ORF2p
presumably takes place at the ribosome (52,53). It has
been hypothesized that the SVA-encoded Alu-like
domain localizes SVA RNA to the ribosome by annealing
with Alu RNAs which were suggested to be docked on
ribosomes via the SRP9/14 complex (52,54). This hypoth-
esis is consistent with our observation that the retrotran-
sposition rate of the SVA reporter element in pAD4/SVAE
which is devoid of hexameric (CCCTCT)n repeats
and Alu-like domain, is reduced in average by 32–46%
(Figure 2A and D) relative to the full-length SVA
reporter element in pAD3/SVAE. A potential relevance
of the Alu-like region for trans-mobilization is also
supported by the ﬁnding that our pSC3/SVAF1 encoded
SVA source element which also lacks the (CCCTCT)n
repeats and almost the entire Alu-like domain exceeds
pseudogene formation rate by only 12-fold while the
canonical SVAE element is trans-mobilized 18-fold
more efﬁciently than the pseudogene in HeLa-HA cells
(Figure 3A and B). Second, the structures of preexisting
SVA insertions imply that several modules of a canonical
full-length SVA element are dispensable and not essential
for successive rounds of retrotransposition. The existence
of SVA2 elements which consist exclusively of VNTRs
fused to short non-SVA sequences and display hallmarks
of L1-mediated retrotransposition (20,21,55), suggests
that the VNTR region is essential for SVA mobilization.
This is supported by the fact that the VNTR region which
can vary in length signiﬁcantly among different SVA in-
sertions, is the only module all mobilized SVA RNAs have
in common. It was suggested that the VNTR alone
or within the context of SVA may increase RNA stability
(24).
We show that the 30 transduction-mediated acquisition
of the AluSp sequence by the SVAF1 source element
H10_1 (pSC4/SVAF1) led to a 3
0-transduced SVAF1
RNA which is mobilized by the L1 protein machinery
25-fold more efﬁciently than the same RNA lacking
the AluSp sequence (pSC3/SVAF1) (Figure 3A and B).
The relatively high trans-mobilization rate of the
30-transduced SVAF1 element H10_1 is obviously based
on the observed preference of L1 proteins for SVA tran-
scripts carrying intact AluSp sequences at their 30-ends and
is consistent with the presence of numerous genomic
SVAF1 copies characterized by the 3
0-transduced AluSp
sequences (21,23,39). The same mechanism hypothesized
recently to be responsible for the preferential trans-
mobilization of Alu elements by the L1-encoded protein
machinery (3,52) could explain the favored mobilization
of SVA RNAs harbouring intact Alu elements at their
30-terminus (21). In this model, the Alu sequence is
docked on ribosomes via the SRP9/14 complex and
captures the L1 ORF2 protein as it is translated from
an active L1 element mRNA (52). Provided that the
30-terminal AluSp elements in SVA transcripts allow
formation of the three-dimensional structure required
for SRP9/14 interaction (56), Alu sequences could
mediate docking of the respective SVA RNA to the
ribosome via SRP9/14 and thus facilitate efﬁcient
capture of ORF2 proteins (3,52,54). Interestingly, the
AluSc element in the 50-region of the SVAF1 source
element (Figure 1A) does not seem to be beneﬁcial for
trans-mobilization, because the canonical SVAE reporter
element in pAD3/SVAE which is devoid of AluSc, is
mobilized at a similar frequency (18-fold) as the
SVAF1 source element in pSC3/SVAF1 (12-fold)
(Figure 3B).
Comparison of trans-mobilization rates of SVA and Alu
elements
The trans-mobilization frequency of our canonical SVAE
reporter element in HeLa cells after hygromycin selection
equates to a relative retrotransposition rate of 0.4–0.9%
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as to the cis retrotransposition frequency of the pJM101/
L1RP-encoded functional L1RP element which was set as
100% (Figures 2A and 3B). Trans-mobilization of the
full-length SVAE reporter element exceeded pseudogene
formation rates of 0.01–0.04% in HeLa-JVM and
HeLa-HA cells by 2- to 5-fold and 18-fold, respectively
(Figures 2D and 3B) and coincides well with the processed
pseudogene formation frequencies of 0.01–0.05% reported
previously by Moran et al. (2). Differences in retrotran-
sposition activity between human cell lines have been
reported earlier (50) and are also known to exist
between different HeLa cell lines (Moran and Deininger,
personal communication). The 25-fold increase of the
trans-mobilization rate of the SVAF1 source element
H10_1 after the addition of the intact AluSp sequence
(Figure 3) equates to a relative retrotransposition rate of
11%. This corresponds approximately to the relative
trans-mobilization frequency (10%) of the AluYa5a2
NF1 element (3) which is one of the most active Alus
described to date (53). Trans-mobilization rates of the
canonical SVAE reporter element (pAD3/SVAE, 0.68%)
and the SVAF1 source element that lacks AluSp
(pSC4/SVAF1, 0.43%) are close to the activity of
a subset of polymorphic AluY elements which were
found to reach only 10% of the AluYa5a2 NF1 retrotran-
sposition rate (53). The relative retrotransposition rates of
L1, Alu and SVA elements determined in cell culture
assays do not reﬂect their recently estimated in vivo
retrotransposition rates of one in 212, 21 and 916 births,
respectively (25). One possible explanation for
discrepancies, for example, in the case of SVA and L1
elements, could be an excessive upregulation of SVA
source element transcription in the germ line or during
early stages of embryonal development relative to L1
transcription.
Hancks et al. (50) referred only a 2-fold increase in
trans-mobilization rate of the SVAF1 source element after
acquisition of the 30-transduced AluSp sequence and that
AluY is trans-mobilized 30-fold more efﬁciently than
the AluSp-including SVAF1 element. There are several
differences in the design of SVA reporter and L1 donor
plasmids between the two reports which make a compari-
son of the presented results rather complicated. First, the
30-transduced sequence including the AluSp element in the
SVAF1 reporter used by Hancks and coworkers (50)
differed from the genomic sequence in several nucleotide
substitutions which were reported to affect trans-mobiliza-
tion rates signiﬁcantly. In contrast, nucleotide sequences
of all SVA reporter elements tested in our study match
genomic sequences. Second, unlike Hancks et al., we
removed transcriptional termination signals at the
SINE-R 30-ends and in the 30-ﬂanking sequence of the
AluSp 30 TSD to ensure transcriptional read-through
into the mneoI cassettes and consistent polyadenylation
at the pCEP4-encoded SV40 polyadenylation signal
(Figure 1A). Third, we fused the mneoI indicator
cassette always with the 30-end of the respective SVA
reporter element, while Hancks and coworkers inserted
this cassette between SINE-R and AluSp sequence of the
SVAF1 element. As a result, the transcriptional start site of
the mneoI cassette is located 430-bp upstream of the
30-end of the SVAF1 RNA, while the transcription start
site of the same cassette in our analogous construct pSC3/
SVAF1 is located at the RNA 3
0-end. Since 50-truncations
occur during SVA trans-mobilization, it could well be that
the location of the indicator cassette upstream of the SVA
30-end leads to the formation of less G418R foci or EGFP
expressing cells in cell culture assays.
SVA de novo insertions bear the hallmarks of mobilization
by the L1 protein machinery
Analysis of pre- and post-integration sites of 11 SVA de
novo insertions uncovered the hallmarks of L1-mediated
retrotransposition. We found variable TSDs of 8–19 bp in
length which correspond well to the TSD lengths of
preexisting genomic L1 insertions ranging from 9 to
27 bp (15). The nucleotide proﬁle of the target sites of
the 11 analyzed SVAE de novo insertions resembles the
L1 consensus target sequence 50-TTTT/AA-30 (Figure 6).
SVA insertions into or next to Alu TSDs can be explained
by the fact that their AT-rich TSDs represent recognition
sequences for the L1 endonuclease in an otherwise
AT-poor environment (Figure 5).
Poly(A) tail lengths of SVA de novo insertions (30–78 nt)
exceeded those of pre-existing SVAs (2–72 nt) (21) signiﬁ-
cantly. Similar differences have been reported for L1
de novo insertions (3–150 nt) and preexisting L1s (approxi-
mately 13 adenosines) (43,57). One reason for the
differences in polyA tail lengths between preexisting and
de novo insertions might be the fact that each de novo
insertion derived from an SVAE reporter cassette was
polyadenylated at the sole SV40pA site present at the
30-end of the reporter construct (Figure 1A), while
RNAs derived from genomic SVA insertions are
polyadenylated at sites encoded by the SINE-R region.
We found 9/11 (82%) SVA de novo insertions to
be full-length covering 3.35 and 2.85 kb, respectively
(Figure 5 and Supplementary Table S2). Full-length inser-
tions included the entire spliced transcript expressed from
the SVA retrotransposition reporter cassette, starting with
position+3 or+4 relative to the transcriptional initiation
site of the CMV promoter. The fact that the percentage of
63% of preexisting full-length SVA insertions differs
from the proportion of de novo full-length insertions
could be a consequence of the relative small number of
analyzed de novo insertions relative to the statistically
more signiﬁcant pool of 2760 preexisting SVAs
analyzed by Wang et al. (12). Since it was reported that
the length of de novo insertions generated by L1 proteins
in trans depends on the activity of this particular L1
element (58), the observed difference might alternatively
be attributed to the use of L1RP, one of the most active
human L1 elements identiﬁed to date (59), as L1 protein
donor in our reporter assays. In vivo trans-mobilization of
genomic SVA elements, however, is probably mediated by
a multitude of different functional L1 elements with most
of them being less active than L1RP (59). Therefore, lower
frequencies of endogenous full-length SVA retrotran-
sposition events would be expected. In the case of L1,
only 6% of all de novo retrotransposition events
(43–45) and 5% of preexisting copies (15) are full-length.
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Clearly, one reason for the signiﬁcantly larger fraction of
full-length SVA elements compared to L1 is the fact
that L1 RT can process more of the comparatively
short full-length SVA-encoded mRNAs which are only
700–4000 bp in length (12,23) than 6-kb transcripts that
are encoded by full-length L1s. Since the average size of
recovered L1RP de novo insertions is 3165 bp (44), and
our de novo SVA full-length insertions are 3303 or 2805 bp
in length (Supplementary Table S2), one would expect an
increased rate of full-length SVA insertions. The fact that
L1 RT successfully reverse transcribes the GC-rich VNTR
region of the SVA reporter elements militates against the
hypothesis that L1 50-truncations are a consequence of an
extenuated L1 RT activity. Hancks et al. reported that
mobilization of an SVAE source element that was not
under transcriptional control of an external promoter
generated only 50-truncated de novo insertions (50).
This result suggests that SVA elements per se do not
include strong promoter sequences that could facilitate
full-length transcription, and that mneoI insertions
derived from the promoterless SVAE reporter might
have been produced from a cryptic promoter located
upstream of the SVA sequence on the reporter plasmid.
Alternatively, these SVAE insertions might not represent
50-truncations at all and SVA transcription started within
the VNTR region as numerous transcription start sites
exist throughout the SVA sequence (23,50).
We found untemplated G nucleotides at the 50-end
of three full-length SVA de novo insertions. They have
been described originally for L1 insertions (60) and were
attributed to reverse transcription of the 7-methyl
guanosine cap (44). Endogenous SVAs are very likely
transcribed by RNA polymerase II. 50 capping of SVA
RNAs was suggested in earlier reports because of the
presence of guanosine residues at the 50-end of about
33% of pre-existing SVA insertions (12). The 5/11 inser-
tions are characterized by short patches of microcomple-
mentarity of 1–2 nt at the junctions between SVA 50-end
and TSD. Such short patches of microhomology were
reported earlier for L1 50 junctions (36) and indicate the
involvement of double strand break repair by error-prone
non homologous endjoining (NHEJ) in the attachment
of the SVA 50-end to the chromosomal DNA.
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